NEW YORK MiMedx Group Inc finalized a deal Sunday to acquire Stability Biologics for $10 million in cash and stock.
The regenerative medicine company MiMedx said the acquisition of Stability Biologics, a provider of human tissue and bone graft products, adds a new sales channel and roughly 100 salespeople to the company.
12:45 Oasis Petroleum offers stock to raise funds for Bakken purchase
21:31 Time Warner jumps after hours on report it could sell for $110 per share to AT&T
18:04 US stocks hold higher after release of Fed's Beige Book; energy rises 2%
17:06 Harley-Davidson says laid off temp workers last quarter